REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Five-membered Hetero Ring Containing At Least One Nitrogen Ring Atom (e.g., 1,2,3-triazoles, Etc.) > Tetrazoles (including Hydrogenated) > 1,2,4-triazoles (including Hydrogenated) 1,2,4-triazoles (including Hydrogenated)1,2,4-triazoles (including Hydrogenated) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/18/07 - 20070015806 - Novel formulation The present invention provides a liquid formulation comprising a strobilurin fungicide, such as azoxystrobin, at least one non-ionic surfactant, at least one anionic surfactant and a solvent/carrier. ... 11/30/06 - 20060270724 - Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders wherein Q is an optionally substituted phenyl; L is a bond or O; P is a benzene or an optionally substituted thiazole ring; and R1 has the values provided herein. The present invention also provides compositions, uses, and methods for use of the compounds, for instance, for treatment of type ... 10/19/06 - 20060235064 - Method of protecting a soybean plant with flutriafol This invention relates to a method of protecting a soybean plant or the seed from which it is grown from foliar diseases, such as rust diseases, using the compound flutriafol. This invention also relates to a method of protecting a plant from soybean rust diseases using the compound flutriafol. ... 10/19/06 - 20060235063 - Method of protecting a soybean plant with flutriafol This invention relates to a method of protecting a soybean plant or the seed from which it is grown from foliar diseases, such as rust diseases, using the compound flutriafol. This invention also relates to a method of protecting a plant from soybean rust diseases using the compound flutriafol. ... 08/24/06 - 20060189670 - Process for the preparation of anastrozole and intermediates thereof wherein Z is a protecting group to produce 2,2′-[5-(4-Z-1,2,4-triazolium-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile) halide; and (b) deprotecting the 2,2′-[5-(4-Z-1,2,4-triazolium-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile)halide to produce anastrozole. Also provided is anastrozole substantially free of its isomers. ... 07/27/06 - 20060167070 - Triazole compounds that modulate hsp90 activity The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising ... 06/29/06 - 20060142362 - Heteroarylacetamide inhibitors of factor xa wherein Ra to Re are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments. ... 06/29/06 - 20060142361 - Azole derivatives and methods for making the same The present invention is broadly directed to azole derivatives that exhibit antifungal activity and methods for making the same. In one aspect, the invention includes carboxylic acid and phosphate ester derivatives of fluconazole that exhibit antifungal activity. In addition, the invention comprises methods for synthesizing the derivatives and pharmaceutical compositions ... 06/29/06 - 20060142360 - Compound wherein each T is independently selected from H, hydrocarbyl, —F—R, and a bond with one of D, E, P or Q, or together with one of P and Q forms a ring; Z is a suitable atom the valency of which is m; D, E and F are each independently ... 06/15/06 - 20060128776 - Opioid receptor active compounds wherein R1 to R4 and n have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I, and therapeutic methods ... 06/15/06 - 20060128775 - Regiospecific process for the preparation of 4-[1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl) methyl] benzonitrile A regiospecific process for the preparation of 4-[1-(4-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile comprising reacting 4-halomethylbenzonitrile with 4-amino-1,2,4-triazole followed by deamination and reaction with 4-fluorobenzonitrile. ... 06/01/06 - 20060116411 - Medicinal composition containing triazole compound A pharmaceutical composition containing a triazole compound which is (2R,3R)-3-[[trans-2-[(1E,3E)-4-(4-cyano-2-fluorophenyl)-1,3-butadien-1-yl]-1,3-dioxan-5-yl]thio]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol and at least one pharmaceutically acceptable basic substance, wherein a ratio of the triazole compound to the basic substance is 1:0.01 to 1:10; the triazole compound is in an amount of 1 to 2000 mg; and the composition has an ... 05/11/06 - 20060100259 - Process for the preparation of substituted triazole compounds The present invention is directed to a novel process for the preparation of substituted triazole compounds, useful in the treating or ameliorating a selective kinase or dual-kinase mediated disorder. The process of the present invention preferentially produces the desired regioisomer of the substituted triazole compounds. ... 04/06/06 - 20060074118 - 1, 2, 4 - triazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same A 1,2,4-triazole derivative of formula 1 or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided. ... 02/16/06 - 20060035950 - Novel processes for preparing substantially pure anastrozole The present invention provides novel processes for purifying anastrozole, devoid of using liquid chromatography. The purification processes are via the isolated anastrozole salt forms, either by crystallization or by selective acidic extractions, and optionally in both cases, converting the purified anastrozole salt to anastrozole base. Also provided is an improved ... 02/02/06 - 20060025461 - Triazole derivative The invention relates to a triazole derivative with an activity inhibiting glycine transporter and for use as a pharmaceutical drug, and a novel triazole derivative. The inventive triazole derivative has an excellent activity inhibiting glycine transporter and is useful as a therapeutic agent of dementia, schizophrenia, cognitive disorders, or cognitive ... 01/26/06 - 20060020006 - Substituted triazoles as sodium channel blockers Substituted triazole compounds represented by Formula I, II or III, or pharmaceutically acceptable salts thereof. Pharmaceutical compositions comprise an effective amount of the instant compounds, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier. Methods of treating conditions associated with, or ... 01/12/06 - 20060009503 - Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma The present invention provides benzodifuran imidazoline derivatives and benzofuran imidazoline derivatives for lowering intraocular pressure and providing ocular neuroprotection. ... 01/05/06 - 20060004069 - Agent for preventing or treating neuropathy The present invention provides an agent for preventing or treating neuropathy having superior action and low toxicity. This agent comprises a compound represented by the formula: wherein ring A is a 5-membered aromatic heterocycle containing 2 or more nitrogen atoms, which may further have substituent(s); B is an optionally substituted ... 12/29/05 - 20050288347 - Certain triazole-based compounds, compositions, and uses thereof Thiotriazole-based chemical entities exhibiting ATP-utilizing enzyme inhibitory activity, methods of using such chemical entities, and compositions comprising such chemical entities, are described. ... 12/22/05 - 20050282878 - Process for the purification of fluconazole The present invention relates to processes for the purification of crude fluconazole including at least a first leaching, a second leaching, and an acid/base treatment and to highly purified fluconazole produced from the processes. ... 12/01/05 - 20050267185 - 1,2,4-triazole derivatives, compositions, process of making and methods of use Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity. ... 12/01/05 - 20050267184 - 3-aminocarbonyl substituted benzoylpyrazolones In this formula (I) R1a, R1b, R1c, R2, R3, R4 and R5 stand for various radicals, X for a bridging atom, L for a carbon chain and Y for a chalcogen atom. ... 10/20/05 - 20050234117 - Triazoles as farnesyl transferase inhibitors R3 is aryl, —NR5R6, a substituted or unsubstituted C1-14heterocycle, or C2-4alkenediyl substituted with a substituted or unsubstituted C1-14heterocycle or aryl; R4 is hydrogen, aryl, C3-7cycloalkyl, C1-6alkyl or C1-6alkyl substituted with C3-7cycloalkyl, hydroxycarbonyl, C1-4alkyloxycarbonyl or aryl; R5 and R6 are each independently selected from hydrogen, a substituted or unsubstituted C1-14heterocycle, aryl, ... 10/06/05 - 20050222234 - Mucin production inhibitor (wherein A represents a triazole group; R1 and R2 may be identical to or different from each other, and each represents an aliphatic hydrocarbon group which may have an alicyclic hydrocarbon group, or an alicyclic hydrocarbon group; R3 represents a hydrogen atom or a substituent; and R4 represents a hydrogen ... 09/22/05 - 20050209294 - Process for producing 4-(1h-1,2,4-triazol-1-ylmethyl)benzonitrile The invention discloses an improved process for producing 4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile of Formula (Structure 2), an intermediate used in the manufacture of 4,4′-[1H-1,2,4-triazol-1-ylmethylene] bisbenzonitrile (Letrozole), the process comprising of reacting salt of 1,2,4-triazole of Formula (Structure 4) with α-halo substituted tolunitrile of Formula (Structure 3) in presence of dimethylformamide, wherein the X ... 09/08/05 - 20050197374 - New long acting beta-2 agonists and their use as medicaments wherein the groups R1, R2, R3, R4 and n may have the meanings given in the claims and in the specification, and methods for preparing a pharmaceutical composition for the treatment of inflammatory and obstructive respiratory complaints. ... 08/25/05 - 20050187275 - Triazoles as oxytocin antagonists The present invention relates to triazole derivatives of formula (I) notably for use as pharmaceutically active compounds, as well as pharmaceutical formulations containing such triazole derivatives. Said triazoles are useful in the treatment and/or prevention of preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, ... 08/18/05 - 20050182116 - Substituted triazole diamine derivatives as kinase inhibitors The present invention provides substituted triazole diamine derivatives as selective kinase or dual-kinase inhibitors and a method for treating or ameliorating a selective kinase or dual-kinase mediated disorder. ... 07/28/05 - 20050165077 - Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage The present invention refers to a treatment for mixed infectious diseases in the human reproductive system, wherein an association of compounds containing fluconazole and either tinidazole is used, the same being associated in doses lower to those commonly used therapeutically. The combination has proven to be highly efficacious and shown ... 07/28/05 - 20050165076 - Fungicidal mixtures based on triazoles in a synergistically effective amount is described. ... 07/14/05 - 20050154038 - Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 Triazole derivatives of structural formula I are selective inhibitors of the 11β-hydroxysteroid dehydrogenase-1. The compounds are useful for the treatment of diabetes, such as noninsulin-dependent diabetes (NIDDM), hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other symptoms associated with NIDDM. ... 06/16/05 - 20050131041 - Azole derivatives as antifungal agents The present invention relates to novel azole derivatives of Formula I, as potential antifungal agents. This invention also relates to pharmaceutical compositions containing the compounds of the present invention and their use in treating and/or preventing the fungal infections in mammals, preferably humans. ... ### FreshPatents.com Support |